Other
maximal inspiratory pressure
maximal inspiratory pressure is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Real-time Effort Driven VENTilator Management
NCT03266016
completed
Respiratory Muscle Strength and Exercise Capacity in Smokers
NCT06650150
completed
Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease
NCT02354664
completed
Correlation of the Hand Grip Force With Maximum Inspiratory and Maximum Expiratory Pressure, in Critical Ill Patients
NCT03457376
Clinical Trials (4)
Showing 4 of 4 trials
NCT03266016Not Applicable
Real-time Effort Driven VENTilator Management
NCT06650150
Respiratory Muscle Strength and Exercise Capacity in Smokers
NCT02354664
Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease
NCT03457376
Correlation of the Hand Grip Force With Maximum Inspiratory and Maximum Expiratory Pressure, in Critical Ill Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4